A Multi-center, Open Label, Randomized Parallel Group Study Evaluating the Proportion of Post-menarchal Women With Complete Resolution of Nonatypical Endometrial Hyperplasia Treated With Mirena or Oral Progestin for 6 Months
Latest Information Update: 03 Oct 2025
At a glance
- Drugs Levonorgestrel (Primary) ; Medroxyprogesterone (Primary)
- Indications Endometrial hyperplasia
- Focus Therapeutic Use
- Acronyms SUNFLOWER
Most Recent Events
- 03 Sep 2025 Planned primary completion date changed from 6 Jan 2027 to 20 Jan 2027.
- 03 Sep 2025 Planned initiation date changed from 5 Sep 2025 to 1 Dec 2025.
- 22 Jun 2025 Planned End Date changed from 6 Jan 2027 to 20 Jan 2027.